Form 4 for VKTX Viking Therapeutics, Inc.
Accepted 2025-10-28 00:00:00 ET · period of report 2025-10-27 · accession 0001193125-25-254300 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-10-28 | 2025-10-27 | VKTX | Rowland Charles A Jr | Dir | S - Sale | $35.57 | -60.0K | 30.0K | -67% | -$2.13M |
| DM | 2025-10-28 | 2025-10-27 | VKTX | Rowland Charles A Jr | Dir | A - Grant | $5.11 | +60.0K | 46.0K | New | +$306.6K |
| DM | 2025-10-28 | 2025-10-27 | VKTX | Rowland Charles A Jr | Dir | M - OptEx | $0.00 | -60.0K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock, par value $0.00001 per share | 2025-10-27 | S | D | 60,000 | $35.57 | 30,000 | D | — | — | (F1) The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $35.02 to $35.94, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. |
| 2 | Common | Common Stock, par value $0.00001 per share | 2025-10-27 | A | A | 22,000 | $4.88 | 90,000 | D | — | — | |
| 3 | Common | Common Stock, par value $0.00001 per share | 2025-10-27 | A | A | 22,000 | $5.80 | 68,000 | D | — | — | |
| 4 | Common | Common Stock, par value $0.00001 per share | 2025-10-27 | A | A | 16,000 | $4.48 | 46,000 | D | — | — | |
| 5 | Derivative | Stock Option (Right to Buy) | 2025-10-27 | M | D | 22,000 | $0.00 | 0 | D | $4.88 · 2023-01-03 to 2032-01-03 | 22,000 Common Stock | |
| 6 | Derivative | Stock Option (Right to Buy) | 2025-10-27 | M | D | 22,000 | $0.00 | 0 | D | $5.80 · 2022-01-04 to 2031-01-04 | 22,000 Common Stock | |
| 7 | Derivative | Stock Option (Right to Buy) | 2025-10-27 | M | D | 16,000 | $0.00 | 0 | D | $4.48 · 2019-01-02 to 2028-01-02 | 16,000 Common Stock |